• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYSB2400305 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2024-11-21 Guangdong Shuanglin Bio-Pharmacy Co Ltd view
CYSB2400277 静注人免疫球蛋白 human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2024-10-23 Hualan Biological Engineering Inc view
CYSB2400278 静注人免疫球蛋白 human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2024-10-23 Hualan Biological Engineering Inc view
CYSB2400270 破伤风人免疫球蛋白 human tetanus immunoglobulin Injection Biological Products Supplementary Application 2024-10-13 Sichuan Yuanda Shuyang Pharmaceutical Co Ltd view
CYSB2400267 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2024-10-10 Guangdong Shuanglin Bio-Pharmacy Co Ltd view
CYSB2400253 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2024-09-26 Sinopharm Kunming Blood Products Co Ltd view
CYSB2400252 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2024-09-26 Sinopharm Kunming Blood Products Co Ltd view
CYSB2400260 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(3.4) Supplementary Application 2024-09-26 Shanxi Kangbao Biological Product Co Ltd view
CYSB2400223 人免疫球蛋白 human immunoglobulin Injection Biological Products Supplementary Application 2024-08-21 Shandong Taibang Biological Products Co Ltd view
CYSB2400222 人免疫球蛋白 human immunoglobulin Injection Biological Products Supplementary Application 2024-08-21 Shandong Taibang Biological Products Co Ltd view
CYSB2400198 乙型肝炎人免疫球蛋白 human hepatitis B immunoglobulin Injection Biological Products(原15) Supplementary Application 2024-08-07 Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd view
CYSB2400197 乙型肝炎人免疫球蛋白 human hepatitis B immunoglobulin Injection Biological Products(原15) Supplementary Application 2024-08-07 Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd view
CXSS2400081 破伤风人免疫球蛋白 human tetanus immunoglobulin Injection Biological Products(3.4) New Drug Application 2024-07-31 China Resources Boya Bio-pharmaceutical Group Co Ltd view
CXSL2400434 皮下注射人免疫球蛋白 Lyophilized Biological Products(3.2) New Drug Application 2024-07-08 Sichuan Yuanda Shuyang Pharmaceutical Co Ltd view
CXSL2400412 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(3.2) New Drug Application 2024-06-26 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2400143 狂犬病人免疫球蛋白 human rabies immunoglobulin Injection Biological Products(3.4) Supplementary Application 2024-06-04 Hualan Biological Engineering Chongqing Co Ltd view
CYSB2400114 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2024-05-15 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2400096 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2024-04-25 Green Cross China Biological Products Co Ltd view
CYSB2400097 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2024-04-25 Green Cross China Biological Products Co Ltd view
CYSB2400098 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2024-04-25 Green Cross China Biological Products Co Ltd view